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Fgf signaling via Erk activation has been associated
with both neural induction and the generation of a
primed state for the differentiation of embryonic
stem cells (ESCs) to all somatic lineages. To dissect
the role of Erk in both ESC self-renewal and lineage
specification, we explored the requirements for this
pathway in various in vitro differentiation settings. A
combination of pharmacological inhibition of Erk
signaling and genetic loss of function reveal a role
for Erk signaling in endodermal, but not neural differ-
entiation. Neural differentiation occurs normally
despite a complete block to Erk phosphorylation. In
support of this, Erk activation in ESCs derepresses
primitive endoderm (PrE) gene expression as a
consequence of inhibiting the pluripotent/epiblast
network. The early response to Erk activation corre-
lates with functional PrE priming, whereas sustained
Erk activity results in PrE differentiation. Taken
together, our results suggest that Erk signaling sup-
presses pluripotent gene expression to enable endo-
dermal differentiation.
INTRODUCTION
Mouse embryonic stem cells (ESCs) are immortal, karyotypically
stable cell lines derived from the inner cell mass (ICM) or early
epiblast of preimplantation embryos (Evans and Kaufman,
1981; Martin, 1981; Najm et al., 2011). They are capable of main-
taining their differentiation potential through multiple rounds of
division, of differentiating into all the lineages of the future
conceptus when reintroduced into a developing embryo (Mor-
gani et al., 2013; Robertson et al., 1986), and of undergoing
directed differentiation in vitro. ESCs are defined by these func-
tional properties, self-renewal, and pluri- (and in some cases
toti-) potency, but they are also characterized by the expression
of an array of genes, primarily transcription factors such as
Nanog, Oct4, Rex1 (Chambers et al., 2003; Mitsui et al., 2003;
Nichols et al., 1998; Takahashi and Yamanaka, 2006), and cell-
surface markers including SSEA1 and PECAM1 (Canham et al.,
2010; Rugg-Gunn et al., 2012).
The maintenance of ESCs in an undifferentiated state is
dependent on external signals such as leukemia inhibitory factor2056 Cell Reports 9, 2056–2070, December 24, 2014 ª2014 The Aut(LIF) (Smith et al., 1988) and BMP4 (Ying et al., 2003a). It is
thought that these signals converge on a core network of tran-
scription factors that cooperate to maintain an undifferentiated
state (Martello et al., 2012, 2013). Recently, it has been shown
that ESCs can bemaintained in aminimal defined culture system
through the combinatorial inhibition of both Mek-Erk and Gsk3
signaling (Ying et al., 2008). This condition, known as 2i, was
shown to be highly effective at supporting pluripotent ESCs
and, when supplemented with LIF, contains a subpopulation of
single cells that exhibit totipotency (Morgani et al., 2013). The
rationale behind this culture system is that robust Erk activity
(downstream of Fgf4) is essential for multilineage differentiation
of ESCs (Kunath et al., 2007; Ying et al., 2008), and therefore in-
hibiting it promotes self-renewal. The suppression of Gsk3 activ-
ity was believed to enhance the viability of undifferentiated cells
grown in these defined conditions (Ying et al., 2008). However,
recent studies suggest that Gsk3 activity regulates a crucial
axis of the pluripotency network and can regulate self-renewal
independently of Erk inhibition or LIF-Stat3 activation (Wray
et al., 2011).
Although it has been proposed that Erk activity is required for
differentiation toward derivatives of all three germ layers in vitro
(Kunath et al., 2007; Ying et al., 2008), in vivo studies into various
mutants of the Fgf-Erk pathway indicate this pathway is required
for early extraembryonic endoderm differentiation (Chazaud
et al., 2006;Kanget al., 2013), in addition toplaying a role in aiding
the survival of differentiated epiblast derived tissues (Armanet al.,
1998; Feldman et al., 1995; Wilder et al., 1997). It has also been
suggested that Erk activity is required for differentiation toward
neural tissues in vitro (Kunath et al., 2007; Stavridis et al., 2007),
although the in vivo evidence for a requirement for Fgf-Erk
activity in the early stages of neural specification is controversial
(Di-Gregorio et al., 2007). Experiments in chick and Xenopus
disagree as to whether naive ectoderm can undergo neural
induction merely as a result of BMP antagonism, the default
model, or whether neural induction is mediated via an Fgf-Erk
signal (Linker and Stern, 2004). Data from ESCs were seen to
support such a role for Fgf-Erk in neural induction, although it
was recently shown that Erk2, the primary Erk isozyme ex-
pressed in ESCs, is entirely dispensable for their multilineage
differentiation (Hamilton et al., 2013). Moreover, although the
inhibition of Erk activity enhances the differentiation of certain
neural lineages when differentiated from mouse epiblast stem
cells (EpiSCs) (Jaeger et al., 2011), Erk activity is still thought to
be required for the progression of undifferentiated cells into a
primed epiblast state, the first stage in neural differentiation.hors
Because self-renewal and differentiation involve the regulation
of the same developmental step, just in opposing directions, we
sought to examine the role of Erk in this process. We found that
Erk activity itself is dispensable for neural induction and epiblast
differentiation from ESCs but is absolutely required for PrE differ-
entiation. We also found that reduced Erk activity facilitated the
enhanced expression of a range of pluripotency-associated
transcripts under conditions that would normally support PrE
differentiation. To probe the role of Erk in promoting PrE dif-
ferentiation, we designed an inducible system for Erk activation.
We found that our previously described functional PrE priming
was a rapid and primary response to Erk activation, and we
deciphered the transcriptional hierarchy involved in this
process. Thus, in ESCs, as in the blastocyst, Erk signaling regu-
lates PrE lineage resolution and demonstrates that the primary
response to this pathway is the downregulation of the pluripo-
tency network as cells embark on a program of endoderm
differentiation.
RESULTS
Erk Activity Is Dispensable for Neural Induction
from ESCs
Although it is broadly assumed that Erk activity is required for all
epiblast differentiation, the only genetic evidence for a role for
Erk signaling in ESC differentiation toward neural tissue comes
from experiments using Erk2 knockout ESCs, derived from
C56B6/129Ola f1 crosses (Kunath et al., 2007), though it was
subsequently shown that these cells could differentiate in
embryoid bodies (Hamilton et al., 2013). When Erk2 is knocked
out on a pure 129 background, homozygousmutant ESC can un-
dergo normal neural differentiation (Hamilton et al., 2013). How-
ever, these cells are not Erk deficient because they have
compensatory Erk1 activity. Moreover, because spontaneous
neural differentiation has been observed in ESC cultures main-
tained in minimal media (N2B27) containing only a small mole-
cule block to Erk/Mek signaling (Wray et al., 2011; Figure 4C),
we sought to reanalyze the requirement for Erk activity during
the early stages of neural differentiation. We took advantage of
the well-characterized Sox1-GFP reporter line, 46C (Ying et al.,
2003b), which reports on neural progenitor specification during
differentiation, and monitored GFP expression across a time
course of neural differentiation under defined conditions (Ying
et al., 2003b), with or without a pharmacological block to Erk
activation (PD0325901, hereafter referred to as Meki) (Bain
et al., 2007). Sox1-GFP is normally expressed from 48 hr after
the initiation of differentiation. Surprisingly, we observed little
or no change in GFP induction as a result of Meki treatment,
with only a small and insignificant (Student’s t test, p > 0.05)
difference in the percentage of cells expressing Sox1-GFP be-
tween days 3 and 5 (Figure 1A). We confirmed this observation
in the wild-type (WT) ESC line E14Ju (Hamilton et al., 2013), in
which we saw a robust induction of SOX1 protein at day 4 that
coincided with an almost complete downregulation of the ESC
marker OCT4 (Figure 1B). A time course of gene expression anal-
ysis across the first 4 days of differentiation showed that the in-
duction of the master regulator of neural specification, Zfp521
(Kamiya et al., 2011), was unchanged (Figure 1C) when Erk activ-Cell Reity was uniformly inhibited by more than 85% ± 3.5% (Figures
S1A and S1B). Similar to previously reported work (Jaeger
et al., 2011), we saw an upregulation in the ventral midbrain
marker Lmx1a (Chung et al., 2009) (Figure 1C), indicating that
the neural progenitors are capable of responding to Meki. Anal-
ysis of gene expression at day 7 of the protocol showed normal
induction of a range of neural markers (Figure 1D), as well as
expression of morphologically distinct, bIII TUBULIN-expressing
neurons (Figure 1E). Consistent with previously published work
(Lowell et al., 2006), we saw the persistence of someES-like cells
at day 7 of the assay, with a slightly higher percentage persisting
inMeki-treated cultures, as judged by flow cytometry for the cell-
surface marker PECAM1 (Figure 1F). We next looked at how
ESC-associated gene expression changed in our system. Under
self-renewal conditions, inhibition of Erk activity resulted in a sig-
nificant increase in the expression of many ESCmarkers such as
Nanog, Tfcp2l1 (Martello et al., 2013), and Tbx3 (Niwa et al.,
2009) (Figure 1G); however, this difference was lost within
approximately 24–48 hr after differentiation was induced. Thus,
although we observed increased pluripotent gene expression
in response to Meki, differentiation toward neural progenitors
was essentially normal.
We considered whether the lack of efficient inhibition of neural
differentiation was due to the presence of an Erk-dependent
epiblast ‘‘primed’’ population of cells in standard LIF/serum cul-
ture that was able to directly differentiate toward neural lineages,
thus circumventing the Erk requirement (Jaeger et al., 2011). To
eliminate this epiblast-primed population, we precultured cells in
‘‘ground-state’’ ESC culture conditions (Ying et al., 2008). These
conditions, known as 2i, contain both Meki and a Gsk-3b inhib-
itor, Chiron. Preculture in 2i neither inhibited neural differentiation
nor resulted in Erk dependence for Sox1 induction (Figure 1H).
To determine whether this phenomenon was restricted to a spe-
cific ESC genetic background, we compared the ability of
several ESC lines to form neural precursors in the absence of
Erk activity, all from preculture in 2i (Figure S1D), and found
that Erk-independent neural specification was consistent be-
tween 129Ola, C57B6, and 129Ola:C57B6F1 ESCs. In fact, we
found that C57B6 ESCs could only form neural tissue in the
presence of Meki. Furthermore, we tested different sources of
basal media, with and without retinol (which is metabolized to
retinoic acid, a potent inducer of neural identity [Figure S1C]),
two batches of serum, and a variety of sources of Meki (Fig-
ure S1C; data not shown). In all cases, we observed neural in-
duction in the presence of Meki. Thus, it appears that inhibition
of Mek-Erk signaling does not block neural differentiation,
although it supports epiblast/pluripotent gene expression in
the presence of LIF.
TheMek inhibitor PD0325901 is themost specificMek inhibitor
described to date, but it loses specificity for Mek1/2 isoforms at
concentrations greater than 1 mM (Bain et al., 2007). Although
1 mMMeki is sufficient to block acute stimulation with FGF4 (Fig-
ure S2A), to ensure Meki was able to completely suppress
Mek1/2 activity at a dosewhere it would not affect otherMek iso-
forms, we used a combinatorial chemical-genetic approach
where the inhibitory effect of Meki was augmented through ge-
netic depletion of Erk2, the main Erk isozyme expressed in
ESCs (Hamilton et al., 2013). We found that Erk2 mutant ESCsports 9, 2056–2070, December 24, 2014 ª2014 The Authors 2057
Figure 1. Neural Differentiation Can Proceed in the Presence of a Pharmacological Block to Mek-Erk Signaling
(A) Flow cytometry measuring the expression of the neural progenitor reporter Sox1-EGFP in 46C cells treated with either Meki (PD0325901) at 1 mM or DMSO
across a time course of neural differentiation. A slight delay in Sox-GFP induction is observed on days 3–5, whereas cultures are largely indistinguishable with
respect to their Sox1 expression by day 6.
(B) Immunofluorescence analysis of day 4 neural differentiation of the ESC line E14Ju confirming the presence of SOX1 (green) protein in both conditions. DNA is
counterstained with DAPI, and cells were also stained for OCT4 (red).
(legend continued on next page)
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exhibited a dramatic increase in drug sensitivity compared toWT
ESCs, with a 50% reduction in the IC50 for PD0325901 (WT:
60 nM, Erk2/:30 nM), which correlated with a decrease in the
phosphorylation of the Erk1/2 substrate p90Rsk (Figures S2B
and S2C). We therefore analyzed the phenotype of these Erk2
mutant ESCs treated with varying concentrations of Meki in
both self-renewing and differentiating conditions. Consistent
with our previous observations, even with this heightened sensi-
tivity, Meki was unable to block neural differentiation (Figure 2A),
with expression of neural markers Ngn2 and Nestin (Couillard-
Despres et al., 2008) being similar between genotypes and con-
ditions (Figure 2B). We did however note an inverse correlation
between Nanog expression under self-renewing conditions and
levels of Erk phosphorylation, such that in Erk2 mutants, Nanog
expression plateaued at 0.3 mM Meki (Figure 2B), and this was
also the point where we observed saturating inhibition of Erk ac-
tivity (Figure 2C; Figure S2A). Based on the capacity of Erk2(/)
ESCs to differentiate normally in concentrations of Meki that
completely block all Erk phosphorylation, we conclude that Erk
activation is not required for progression in neural differentiation.
Erk Signaling Is Required for PrE Differentiation
In vivo, Fgf4 is the major determinant of the segregation of
epiblast and PrE. Fgf signaling is also required for the conversion
of ESCs to extra embryonic endodermal stem (XEN) cell lines
(Cho et al., 2012), but it is unclear whether this requirement
occurs at the level of Erk signaling or in other pathways down-
stream of Fgf. Moreover, because we found that Erk signaling
was not required for epiblast or neural specification, we thought
it was important to test the requirement for Erk signaling in PrE
differentiation from ESCs and determine whether it is required
at the level of cell specification or expansion. We induced cells
to differentiate by LIF withdrawal in either monolayer culture (Fig-
ures 3A and 3B), or as 3D aggregates (Figures 3C–3E), both of
which allow PrE differentiation (Canham et al., 2010; Morgani
et al., 2013). We found that Erk inhibition led to a robust block
to endodermal differentiation. Antibody staining showed that
Meki inhibited the expression of the PrE marker Gata6 in these
cultures, while sustaining Oct4 expression (Figure 3A). Figure 3B
shows flow cytometry assessing induction of the early endo-
dermal marker PDGFRA alongside the ESC marker PECAM1
(Rugg-Gunn et al., 2012), following 5 days of differentiation in
the absence of LIF. Meki completely blocked this differentiation
resulting in a homogenous population of PECAM1-positive
PDGFRA-negative ES-like cells. Importantly, we noted no differ-
ence in the number of cells in these cultures, suggesting this
phenotype is not a result of selective cell survival. Moreover, a
similar block to differentiation was observed when cells were(C) Real-time qPCR assays showing the expression of early neural (Zfp521)
differentiation.
(D) Real-time qPCR assays showing the expression of the indicated neural mark
(E) Immunofluorescence analysis of day 7 neural differentiation of ESC line E14Ju f
counterstained with DAPI (purple).
(F) Flow cytometry reporting on the presence of ESCs (PECAM1-positive) follow
(G) Real-time qPCR analysis for the expression of various ESC markers at the in
(H) Flow cytometry for Sox1-GFP expression following neural differentiation from
no difference was observed in the extent of Sox1-GFP induction.
All data are presented as the mean ± SD of independent experiments, except for
Cell Recultured as hanging-drop embryoid bodies, and then allowed
to adhere and outgrow. This method gives a high proportion
of PrE cells (PDGFRA-positive, GATA6-positive) that was
completely lost when cells were differentiated in the presence
of Meki (Figures 3C and 3D). Real-time quantitative PCR
(qPCR) shows that ESC markers Oct4, Sox2, and Nanog were
sustained in the presence of Meki, whereas the normal induction
of the PrE markers Pdgrfa, Gata6, Sox7, and Sox17 (Artus et al.,
2011) was inhibited (Figure 3E). Taken together, these data
demonstrate an absolute requirement for Erk activation in PrE
specification.
Erk Induction Promotes PrE by Suppressing Epiblast
Identity in ESCs
We investigated the transcriptional response to Erk in ESCs by
engineering an inducible gain-of-function model. We generated
a constitutively active form of c-Raf, an effector kinase upstream
of Mek-Erk, which lacked the Erk-dependent repressive do-
mains (c-RafD26–303) (Samuels et al., 1993) and fused it to two
different drug-inducible peptides. At the amino terminus, we
introduced an FKBPL106P tag (Banaszynski et al., 2006), that tar-
gets the protein for degradation in absence of the small mole-
cule, Shld1. At the carboxyl terminius, we fused a variant of the
ligand binding domain of the estrogen receptor that binds selec-
tively to 4-hydroxy tamoxifen (4OHT). The resulting fusion protein
(FCXCT2) (Figure 4A) enabled the induction of Erk phosphoryla-
tion in response to 4OHT and Shld1. To ensure that the major
source of Erk signaling in this systemwas derived from the exog-
enous FCXCT2, cells were cultured in the presence of a small
molecule inhibitor of the Fgf receptor PD173074 (Fgfri), for
24 hr prior to induction, alongside Shld1 to stabilize the fusion
protein, with both drugs present during the time course of
4OHT stimulation. Given that Erk signaling is required for PrE
specification in the preimplanation mammalian embryo from
which ESCs are derived (Nichols et al., 2009), we introduced
the FCXCT2 construct into the Hhex-venus (HV) knockin line
that has been shown to be a sensitive reporter for PrE priming
and specification (Canham et al., 2010; Morgani et al., 2013).
This cell line enables the isolation of ESCs that are primed
(biased) toward, but not yet committed to, PrE as well as
providing a sensitive reporter for PrE differentiation. Following
stabilization and induction of FCXCT2, a rapid and sustained in-
crease in pErk was detected that could be blocked if induction
was performed in the presence of Meki (Figure 4B). To ensure
that FCXCT2 activity was not affecting parallel signaling path-
ways, we analyzed the phosphorylation status of components
of the LIF-STAT3, Akt, Gsk3-b-catenin, and BMP-SMAD
pathways and found only minimal sporadic changes inand ventral midbrain marker (Lmx1a) at the indicated times during neural
ers following 7 days of neural differentiation.
or the neural marker bIII tubulin (yellow) and the ESCmarker OCT4 (red). DNA is
ing 7 days of neural differentiation, DMSO <1%, Meki4% PECAM1 positive.
dicated times.
cells grown in either serum-free ‘‘2i’’ or standard serum:LIF culture conditions;
Figure 1D, which is the mean ± SD of parallel experiments. See also Figure S1.
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Figure 2. Acute Attenuation of Erk Activity in Erk2(/) ESCs Fails to Inhibit Neural Differentiation
(A) Immunofluorescence for bIII-TUBULIN (red) and NANOG (green) following 7 days of neural differentiation of the Erk2(/) or E14Ju parental-control ESCs in the
presence of the indicated concentration of Meki. Cultures were largely identical except for a slight decrease in overall numbers of Erk2 knockout cells present in
cultures treated with 1 mM Meki. DNA is counterstained with DAPI.
(legend continued on next page)
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phosphorylation of these components despite 24 hr of sustained
Raf-Erk induction (Figure 4C). Furthermore, following FCXCT2 in-
duction, Erk activity was detected in both the nucleus and the
cytoplasm, which could again be blocked by Meki (Figure 4D).
Next, we analyzed PrE priming in response to Erk by moni-
toring Hhex RNA and HV expression. Flow cytometry for venus
fluorescence and real-time qPCR for Hhex expression showed
a dramatic increase in promoter activity following 24 hr of
FCXCT2/Erk induction. This induction was also blocked by
cotreatment with Meki (Figures 4E and 4F). Although Erk activity
has been reported to be dispensable for ESC proliferation
(Ying et al., 2008), we saw a decrease in the percentage of cells
in S phase when Erk activity was inhibited by Fgfri, which could
be rescued by activation of downstream c-Raf/Erk (Figure 4G).
Because the efficiency of self-renewal (Coronado et al., 2013)
and lineage potential (Calder et al., 2013) have been linked to
cell-cycle position, we asked whether Erk-dependent progres-
sion into S phase might stimulate Hhex expression. When cells
were sorted based on their DNA content/cell-cycle position
and the magnitude of HV induction was measured in each cell-
cycle position, we did not observe any cell-cycle-dependent dif-
ferences in the magnitude of venus fluorescence (Figure S3A).
Taken together, we conclude that Erk induction can stimulate
G1/S progression and PrE differentiation, but these events do
not appear to be linked.
To understand the transcriptional mechanisms downstream
of Erk induction, we performed a time course of microarray
expression analysis across the first 24 hr of Erk induction (Fig-
ure 5A) (GEO accession number GSE59755). The earliest genes
induced (60 min) were the canonical FGF-Erk immediate early
genes (IEG) cFos and Egr1 (Hamilton et al., 2013). The tran-
scriptional response increased over time, and by 24 hr the
expression of over 13,000 genes had changed by at least
2-fold (Table S1).
We have described several functionally distinct subpopula-
tions in self-renewing ESC cultures based on the differential
expression of HV and the cell-surface marker, SSEA1 (Canham
et al., 2010; Morgani et al., 2013) (Figure 5B). Coexpression of
HV and SSEA1 (HV+S+) marks a PrE-primed self-renewing sub-
population of ESCs. Cells in this population exhibit a PrE bias
in differentiation but self-renew in standard ESC conditions.
HV+S cells are committed to PrE differentiation. HV popula-
tions (both SSEA1+/) represent ESCs primed to differentiate
toward epiblast lineages, such as neural. We have previously
defined gene sets enriched in these populations, depicted in Fig-
ure 4B (Canham et al., 2010), and we assessed their behavior in
our Erk induction time course data set (Figure 5C). We observed
a striking overlap between the genes that were enriched in both
HV+ populations and those induced by Erk activity. Moreover,
genes enriched in the HV populations were repressed by Erk in-
duction. In addition to the overlap of gene expression data sets
observed, we found that genes enriched in the HV/SSEA1(B) Real-time qPCR analysis for both ESC (Nanog andOct4) and neural marker (N
as the mean ± SD of independent experiments.
(C) Western blot for phospho-Erk1/2 (pTEpY) before and after neural different
membrane and are therefore comparable. No phospho-Erk1 could be detected
See also Figure S2.
Cell Redouble-positive, PrE-primed population were induced earlier
(beginning at 240 min) than those enriched in the HV-positive,
SSEA1-negative, PrE differentiated population, indicating that
our Erk induction data set captures the transcriptional hierarchy
of PrE priming and differentiation. Because activation of FgfR2
signaling had been shown to repressNanog expression (Santos-
tefano et al., 2012), we asked how an extended list of ESC
markers, defined as having an ESC restricted expression pattern
(Mitsui et al., 2003), responded to Erk induction (Figure 5D). We
observed early repression of many genes whose expression has
been reported to be heterogeneous in ESCs, and whose forced
overexpression supports LIF-independent self-renewal (Cham-
bers et al., 2003; Festuccia et al., 2012; Martello et al., 2013; Mit-
sui et al., 2003; Niwa et al., 2009). In summary, the use of our
inducible model shows Erk to be the master regulator of PrE
priming and differentiation. The difference between these cell
states is determined by the duration of Erk activation.
Erk Targets Nanog to Derepress Gata6
In the blastocyst, the time preceding the segregation of epiblast
and PrE lineages is marked by a period of transcriptional hetero-
geneity, with differential and overlapping expression of either
Nanog or Gata6 (Chazaud et al., 2006; Frankenberg et al.,
2011; Guo et al., 2010). Mutual antagonism between these two
transcription factors is thought to be a mechanism of lineage
segregation (Mitsui et al., 2003; Singh et al., 2007). Because of
the high degree of temporal resolution in our data set, we were
able to ask whether Erk activity directly regulated the expression
of Gata6 or Nanog. We observed repression of both Nanog
mRNA and protein (Figures 6A and 6B) occurred at 4 hr, which
preceded the induction ofGata6 between 8 and 24 hr (Figure 6C).
We then asked whether the repression of the Nanog promoter
was direct. To do this, we induced Erk activity in the presence
or absence of the translational inhibitor cycloheximide and
observed that Nanog expression was repressed following 6 hr
of FCXCT2 induction regardless of whether therewas newprotein
synthesis or not (Figure 6D). Moreover, we used formaldehyde-
assisted isolation of regulatory elements (FAIREs) (Giresi et al.,
2007) to determine whether Erk activation altered the extent of
nucleosome free DNA in the Nanog locus and found the region
to be condensed following 24 hr of Erk stimulation (Figure S4A).
Because our data suggested that suppression of Nanog pre-
ceded any detectable increase in Gata6 expression, we asked
whether forced expression of Nanog could block Erk-dependent
Gata6 induction. We transiently transfected cells with a Nanog-
expressing plasmid, allowed 24 hr for protein synthesis, and
then induced FCXCT2 activity for a further 24 hr (Figure 6E). We
observed a reduction in Erk-dependent Gata6 expression (Stu-
dent’s t test >0.008), when Nanog was exogenously expressed
(Figure 6F); however, the forced expression of Nanogwas unable
to suppress the Erk-dependent repression of a range of epiblast/
pluripotency markers (Figure 6G), even the direct Nanog targetsestin and Ngn2) expression in WT and Erk2 knockout cells. Data are presented
iation. Bands from separate gels were excised and transferred to the same
in Erk2 mutant cells treated with 1 mM Meki.
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Figure 3. Erk Signaling Is Required for PrE Specification
(A) Immunofluorescence images showing the persistence of a largely homogenous OCT4 (red) -positive, GATA6-negative (green), population of cells following
5 days of differentiation in the presence of Meki, in contrast to DMSO-treated cultures.
(B) Flow cytometry for expression of the ESCmarker PECAM1, and the early endodermalmarker PDGFRA at day 0 (2i:LIF), and following 5 days of LIFwithdrawal.
In this context, inhibition of Erk activity did not result in a decrease in the number of cells present at the end of the assay, but a complete block to Pdgfra induction.
Quantitation of the flow cytometry is presented beneath the scatterplots. Data are presented in relative to total cell number.
(C) Immunofluorescence analysis of adherent embryoid bodies following 6 days of differentiation showing almost homogeneous GATA6 (green) induction under
control conditions. In the presence of Meki, only OCT4 (red) -positive, GATA6-negative cells persists.
(D) Flow cytometry showing a complete block in PDGFRA expression in cultures treated with Meki.
(E) Real-time qPCR analysis for ESC andPrEmarkers following 6 days of embryoid body differentiation in the presence or absence ofMeki. Data are normalized to
2i:LIF and presented as the mean ± SD of independent experiments.
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Esrrb and Klf4 (Festuccia et al., 2012). To determine whether the
persistence of Gata6 induction observed under these conditions
was an artifact of the heterogeneous nature of transfection
assays, we generated a Nanog-mCherry fusion protein and
sorted cells that expressed low, physiological levels of NANOG
from transfected populations following FCXCT2 induction (Fig-
ures S4B and S4C). Analysis of endogenous Nanog and Esrrb
expression showed, again, identical levels of repression even
in the presence of exogenous NANOG-mCHERRY; however,
the extent to which Gata6 induction was blocked was now
considerably more pronounced (Figures 6H–6J). Altogether,
our data suggest a model whereby Erk acts directly on the
epiblast/pluripotency network to inhibit transcription, but Nanog
itself is sufficient to block PrE specification through Gata6
repression.
DISCUSSION
In this paper, we have shown that Erk signaling is required for PrE
differentiation and specifically acts to repress self-renewal as a
means to promote differentiation toward this lineage (Figure 7).
Time-limited induction of Erk signaling stimulates PrE priming
in ESC culture including the downregulation of epiblast/pluripo-
tency markers. Although these events are Nanog independent,
the normal induction of PrE gene expression (e.g., Gata6) is sen-
sitive to Nanog levels. Conversely, neural specification proceeds
normally in the absence of detectable Erk activity suggesting
that the enhanced epiblast/pluripotent gene expression
observed in absence of Erk activity has little impact on epiblast
transition and neural differentiation.
Because Erk inhibition resulted in enhanced levels of the ESC
gene regulatory network (GRN), why does this specifically inhibit
endodermal, but not neural differentiation? Perhaps this is
because Erk signaling is fundamentally required for differentia-
tion of the mesoderm and endoderm lineages. In vivo, at the
stage from which ESCs are derived, the relevant mesendoderm
lineage is PrE and Erk regulates the binary choice between
epiblast and PrE. As a consequence, Erk activity in ESC cultures
is associated with downregulating the pluripotency network as
part of the PrE differentiation program. In cells that have already
made the choice to become epiblast, the differentiation program
may involve new factors, such as TFE3, that are independent of
the MAP kinase pathway (Betschinger et al., 2013). Additionally,
inhibitors of Wnt signaling act to downregulate the epiblast
network during differentiation toward gastrulation stage line-
ages. Our data suggest that the Erk-regulated ESC GRN func-
tions largely in blocking endodermal differentiation and that
self-renewal is maintained through repressing predefined line-
age specific programs. Naive pluripotency would therefore be
supported by a combined block to PrE differentiation, through
the inhibition of Erk signaling, and mature ectoderm as a conse-
quence of Wnt stimulation. Consistent with this observation is
our recent finding that ESCs lacking Groucho/TLE corepressors,
antagonist of the Wnt pathway, are unable to progress efficiently
in neural differentiation (Laing et al., 2014).
The requirement for Fgf signaling via Erk activity in the earliest
stepsof differentiation towardaprimed, eggcylinder-likeepiblast
provided a phased model for neural differentiation that requiredCell ReErk stimulation and BMP antagonism (Ying et al., 2003a). Our
data indicate that Erk signaling is not required for differentiation
of naive epiblast into neural progenitors. Consistent with our ob-
servations is the ability of Erk2 mutant ESCs to develop past
epiblast stage in tetraploid chimera experiments with wild-type
extraembryonic tissue (Voisin et al., 2010). What then explains
the requirement for Fgf signaling? Perhaps a role in neural cell
viability manifested itself as induction in earlier studies. Thus,
although Fgf signaling is not necessary for neural induction, it
could be required for cell and this would not have been detected
in previously reported population analyses, primarily flow cytom-
etry and real-time PCR. These observations are consistent with a
requirement for Fgf signaling in the survival of early telencephalic
neurons (Paek et al., 2009), but not in neuroectodermal specifica-
tion (Di-Gregorio et al., 2007). In addition, signaling downstream
of FGF receptors activates the Akt pathway (Ong et al., 2001),
which has been shown to regulate neuronal cell survival (Zhang
et al., 2013). It is also possible that both the antagonism of BMP
signaling andErk activation feed into similar regulatory programs.
Amajor activity downstreamofErk is thepromotionof epithelial to
mesenchymal transition (EMT) (Oki et al., 2010). It was recently
demonstrated that BMP signaling acts through Id proteins to
inhibit neural differentiation in ESCs by suppressing an EMT-
like event (Malaguti et al., 2013). Moreover, a component of the
mechanism by which Oct4 suppresses differentiation is via sus-
tained BMP expression and the maintenance of adherens junc-
tions and E-cadherin expression (Livigni et al., 2013). Thus, it
maybe that Erk activity is required for neural induction in contexts
where inhibition of BMP signaling is not sufficient to promote the
downregulation of E-cadherin on its own. It is intriguing to note
that in the mouse, where BMP antagonism appears sufficient to
induce neural differentiation, there is no evidence for significant
Erk activation in pregastrulation epiblast (Corson et al., 2003),
whereas in chick, where early neural differentiation is Erk-depen-
dent, activated Erk is detected (Lunn et al., 2007).
ESC cultures contain populations of primed epiblast and PrE
cells, and we found that Erk activity suppressed self-renewal
to promote PrE priming. In ESC cultures, this priming is dynamic,
and we observed that the set of early Erk responding genes in
our data set corresponded to genes expressed in primed, but
not differentiated populations of ESCs. Perhaps this means
that the existence of primed states in ESC is a product of the
negative-feedback loops normally restricting the duration of
Erk signaling in ESCs.
In vivo, prior to lineage segregation, blastomeres transiently
coexpress both Gata6 and Nanog. Loss of Fgf4 does not elimi-
nate the early expression of Gata6 (Kang et al., 2013) but results
in a failure of cells to downregulate Nanog and segregate endo-
derm identity. Thus, it may be that Fgf:Erk signaling is essential
to downregulate pluripotency/epiblast-associated genes such
as Nanog, relieving repression of the endodermal GRN and
allowing lineage resolution. In vitro, we found that Erk induction
resulted in suppression of the epiblast/pluripotency network
prior to the induction of Gata6 expression. It therefore seems
likely that the major function of this signaling pathway is to sup-
press epiblast gene transcription thereby enabling the stable
expression of Gata6. Because Nanog overexpression can inhibit
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Figure 4. A Heterologous System for Drug-Inducible Erk Activation
(A) A schematic illustration of the inducible system. The c-Raf fusion protein (FKBPL106P-cRaf-D-cRaf-ErT2:FCXCT2) contains an N-terminal FKBP and C-terminal
mutant estrogen receptor (ERT2) and is constitutively expressed from the CAG promoter in HV ESCs. The Hhex reporter contains a reiterated Gtx IRES element
and intact Hhex cDNA inserted into the first exon of the Hhex genomic locus.
(B) Western blot quantification of Erk phosphorylation following FCXCT2 induction for different periods of time. Data are presented as the mean ± SD of inde-
pendent clones.
(C)Western blot analysis for the phosphorylation status of components of several signaling pathways known to be active in ESCs: Erk1/2 (T183:Y185), STAT3 (T705),
Akt (S473), Gsk3a/b (S21/9), b-catenin (SS33/37:T41), and SMAD1/5 (S463/465), showing only minor fluctuation in their activity across the time analyzed.
(D) Immunofluorescence for pErk1/2 showing a heterogeneous mix of nuclear and cytoplasmic active Erk following FCXCT2 induction.
(legend continued on next page)
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Figure 5. Erk Induction Promotes PrE by Suppressing Epiblast Identity in ESCs
(A) Microarray time course for gene expression induced by FCXCT2 induction. Pairwise comparison (false discovery rate >0.05%, >2-fold expression change,
average of independent clones) between 0 hr and the indicated time points. The earliest genes to be induced were the canonical MAPK targets cFos and Egr1
at 60 min.
(B) Flow cytometry analysis for HV and SSEA1 showing the sorting strategy used in Canham et al. (2010) to identify populations of primed and differentiating PrE
for expression analysis.
(C) A heatmap showing the correlation between Erk regulated targets and their enrichment in each of the indicated populations from Canham et al. (2010). The
expression pattern of genes that were enriched in each population (>2-fold average of two clones) was analyzed in the FCXCT2 data set and presented as fold
change relative to 0 hr. We observed that genes enriched in both HV-positive populations were induced by Erk activity, whereas genes in the HV negative
populations were repressed. Genes enriched in the SSEA1:HV-positive population (A) PrE-primed population were repressed by Fgfri treatment (0 hr) and were
induced early, starting at 240 min. Genes in population (D), which represents differentiating PrE, were induced later at around 8 hr.
(D) A heatmap showing the transcription response of several ESC-associated transcripts (ECATs) including Oct4 and Sox2 in response to Erk activation. The
majority of genes reported to be heterogeneously expressed in ESCs are indicated by the bracket and were rapidly repressed upon FCXCT2 induction.response to Erk, it suggests that individual epiblast transcription
factors are able to directly repress PrE gene transcription, but
not sustain the GRN itself.(E) Cell-cycle analysis showing an Erk-dependent block in G1 progression. Cells
cytometry.
(F andG) FCXCT2 induction results in an increase inHhex promoter activity as judg
mean ± SD of independent clones.
See also Figure S3.
Cell ReErk was recently linked to the induction of developmental
genes via the recruitment of PRC2 and phosphorylation of
Ser5 in the RNA polymerase II CTD (Tee et al., 2014). Thiswere treated as indicated, stained with Hoechst 33342, and analyzed by flow
ed by venus fluorescence (F) and real-time qPCR (G). Data are presented as the
ports 9, 2056–2070, December 24, 2014 ª2014 The Authors 2065
Figure 6. Nanog Expression Inhibits Gata6 Induction but Is Unable to Counteract Erk-Mediated Suppression of Pluripotency
(A) Real-time qPCR showing Nanog mRNA levels in response to FCXCT2 induction.
(B) Western blot quantification showing NANOG protein levels in response to the same treatments as in (A).
(legend continued on next page)
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Figure 7. A Cartoon Illustrating the Role of Erk Signaling in ESC Self-Renewal and Differentiation
Short-term stimulation of Erk signaling results in a cell state transcriptionally similar PrE-primed ESCs. This state is reversible in standard ESC culture, but when
cells are challenged to differentiate they show a bias toward PrE and away from epiblast differentiation. This short-duration stimulation of Erk results in the direct
inhibition of the expression of transcription factors in the epiblast/pluripotency network known to be heterogeneously expressed in ESC, whereas prolonged
stimulation of Erk results in PrE differentiation and the upregulation of Gata6. Nanog is able to block this induction of Gata6, but its expression is insufficient to
counteract the inhibition of the pluripotent/epiblast gene expression in response to Erk activation.conformation is believed to pause RNA polymerase, and
perhaps this regulatory mechanism is relevant to the suppres-
sion of the epiblast/pluripotency network in response to Erk
activation. In this case, activation of Erk could lead to PRC2
recruitment and transcriptional pausing as a first step in the
downregulation of epiblast genes as cells begin to prime for
PrE differentiation. This suggests a permissive rather than induc-
tive paradigm for Erk-mediated lineage specification, whereby
Erk activity acts as a licensing factor, derepressing endoderm
fate by directly repressing epiblast identity.
EXPERIMENTAL PROCEDURES
ESC Culture
ESC lines (Table S2) were maintained in complete ESC medium: GMEM
(Sigma-Aldrich) supplemented with 10% FBS (Gibco), 100 mM 2-mercaptoe-
thanol (Sigma-Aldrich), 1 3 MEM nonessential amino acids, 2 mM L-gluta-
mine, 1 mM sodium pyruvate (all from Gibco), and 1,000 units/ml LIF
(made in house) on gelatinized tissue culture flasks (Corning). For serum-
free culture, ESC lines were maintained in N2B27 (made in house) or from
STEMCELL Technologies, supplemented with 3 mM Gsk3i (Chir99021:
Axon Medchem, or Stemgent), 1 mM Meki (PD0325901: Sigma-Aldrich,
Stemgent, or Axon Medchem) and LIF, and passaged with Accutase
(Sigma-Aldrich). The FGFR inhibitor PD173074 was used at 250 nM and
was from Sigma-Aldrich. Recombinant mouse Fgf4 was from R&D Systems(C) Real-time qPCR showing Gata6 induction does not occur until Nanog levels
(D) Real-time qPCR analysis ofNanog repression following 6 hr of FCXCT2 inductio
of repression with or without protein synthesis.
(E) Western blot showing ectopic expression of NANOG by transient transfection
duction. Cells were transfected with a plasmid expressing aNanog (long isoform)
and FCXCT2 induced for 24 hr. Cells transfected with an identical plasmid-expre
(F) Real-time qPCR showing a reduction in PrE gene expression in cultures exog
(G) Real-time qPCR showing the effect of FCXCT2 induction on expression of th
pressed in these cells. Nanog could increase the expression of these factors in con
expression. Data are presented as the mean ± SD of independent clones.
(H and I) Real-time qPCR analysis of ESC (Pre-Nanog and Esrrb) and PrE (Gata6) e
unable to sustain expression of pluripotency/epiblast markers; however, Gata6 w
technical replicates.
See also Figure S4.
Cell Reand was used at 20 nM. Neural monolayer differentiation was performed as
outlined by Ying et al. (2003b). In brief, cells were collected, washed in
N2B27, and seeded at a density of 104/cm2, with daily media changes. To
differentiate ESCs toward endodermal lineages, cells were plated in com-
plete, serum-containing, ES medium without LIF, at a density of 0.5 3
104/cm2. Embryoid body differentiation was performed by suspending cells
at a density of 1.2 3 104/ml in 30 ml drops for 48 hr and then allowing spheres
to adhere to gelatin coated dishes and expand for a further 4 days. 4-OHT
(Sigma-Aldrich) was used at 250 nM and Shld1 (Clontech Laboratories)
was used at 500 nM. Nanog (ENSMUST00000012540) was cloned from
E14Ju cDNA into the pPyCAG-IP vector (Chambers et al., 2003) by standard
methods. Transient transfection was performed using Lipofectamine 2000
(Life Technologies).
Real-Time qPCR
Total RNA was collected using either Trizol (Invitrogen) or the RNeasy Mini
Kit (QIAGEN). Genomic DNA was eliminated by DNase treatment (QIAGEN),
and 1 mg of total RNA was used for first-strand synthesis with SuperScript III
reverse transcriptase according to the manufacturer’s instructions. cDNA
corresponding to 10 ng total RNA was used for real-time qPCR analysis us-
ing the Roche LC480, and target amplification was detected with the Univer-
sal Probe Library system. See Table S3 for a list of primers and probes
used.
Western Blotting
Blotting was performed as previously described (Hamilton et al., 2013) except
that primary antibodies were detected using fluorescently conjugatedhave been inhibited in response to FCXCT2 induction.
n in the presence or absence of cycloheximide (20 mM) showing similar extents
in cells containing FCXCT2 48 hr posttransfection and 24 hr after FCXCT2 in-
cDNA driven by a CAGs promoter. The following day, the mediumwas changed
ssing mCherry serving as a negative control.
enously expressing Nanog.
e pluripotency network was the same, regardless of whether Nanog was ex-
trol cultures but had no effect on Erk-mediated suppression of pluripotent gene
xpression in sorted populations from Figure S4B. NANOG-mCherry was again
as now even more acutely repressed. Data are presented as the mean ± SD of
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secondary antibodies (Alexa Fluor, Molecular Probes), visualized using a
Chemidoc MP (Bio-Rad) and quantified using ImageJ. See Table S4 for a list
of antibodies and concentrations used.
Immunofluorescence
Cells were washed and fixed in 4% formaldehyde (Fisher Scientific, PI-28906),
blocked, and permeabilized in 5% donkey serum and 0.3% Triton. Antibodies
were incubated overnight in 1% BSA and 0.3% Triton in PBS and subse-
quently visualized with the appropriate secondary (Alexa Fluor, Molecular
Probes).
Flow Cytometry
Cells were dissociated with Accutase and incubated with the appropriate anti-
body in 10% FCS:PBS for 30 min, washed extensively, and analyzed on an
LSRFortessa (BD Biosciences). Dead cells were excluded based on DAPI
inclusion.
Microarray Analysis
Transcriptome analysis was carried out in-house with one-color 8 3 60K
Mouse Gene Expression Microarrays (Agilent Technologies, G4852A) as
per manufacturer’s instructions. Briefly, 150 ng of total RNA was labeled us-
ing the Low Input Quick Amp Labeling Kit (Agilent Technologies, 5190-
2305). Labeled samples were hybridized overnight and then washed and
scanned using the high-sensitivity protocol (AgilentG3_HiSen_GX_1color)
on a SureScan microarray scanner (Agilent Technologies), and probe inten-
sities were obtained by taking the gProcessedSignal from the output of Agi-
lent feature extraction software using default settings. Probe intensities
were analyzed using the NIA Array Analysis tool (http://lgsun.grc.nia.nih.
gov/ANOVA/).
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